Business Context and Reporting Period
This Form 8-K Current Report was filed by Exicure, Inc. on May 13, 2021. The filing reports the appointment of a new Chief Financial Officer and the associated compensatory arrangements. The Company is an emerging growth company incorporated in Delaware, with its common stock trading on the Nasdaq Stock Market under the symbol XCUR.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and corporate governance changes.
Material Changes
The primary material change reported is the appointment of Brian Bock as Chief Financial Officer, effective May 13, 2021. Mr. Bock replaces the previous CFO (not named in this text) and brings extensive experience in healthcare investment banking from Lincoln International, JMP Securities, and RBC Capital Markets.
Compensatory Arrangements and Management Commentary
The Company entered into an employment agreement and a material inducement award agreement with Mr. Bock. Key terms include:
- Base Salary: $405,000 annually.
- Cash Incentive Bonus: Target of 40% of base salary, contingent on performance goals.
- Sign-on Bonus: $120,000 total, payable in two 50% tranches by the end of December 2021 and December 2022. Subject to a one-year quarterly graded clawback.
- Equity Grant: Nonstatutory stock option to purchase 600,000 shares at an exercise price of $1.54 per share (closing price on May 13, 2021).
- Vesting Schedule: 25% vests on the first anniversary of employment; the remainder vests monthly over the subsequent three years.
- Employment Status: At-will employment with no specified term.
The equity grant was made outside the Company's 2017 Equity Incentive Plan as a material inducement under Nasdaq Listing Rule 5635(c)(4).
Investor Verification Checklist
- Verify the full text of the Employment Agreement (Exhibit 10.1) and Inducement Award Agreement (Exhibit 10.2) for specific termination clauses and clawback details.
- Confirm the impact of the 600,000 share option grant on existing shareholder dilution.
- Review the Company's most recent 10-K or 10-Q for current liquidity and cash runway, as this 8-K does not provide financial status.
- Monitor future filings for the vesting status of the sign-on bonus and equity options.